Month: June 2020

AB Šiaulių bankas, įmonės kodas 112025254, buveinės adresas: Tilžės g. 149, Šiauliai, Lietuva.AB Šiaulių bankas gavo su vadovu glaudžiai susijusio asmens pranešimus apie sandorius dėl banko išleistų vertybinių popierių (pridedama).Emitento įgaliotas teikti papildomą informaciją – VP apskaitos departamento direktorė Jolanta Dobiliauskienė, tel. (8 41) 595 669.PriedaiINVL Medio III_20200605_ltINVL_Extremo III_20200605_ltINVL Pensija 1968-1974_20200605_ltINVL Pensija 1975-1981_20200605_ltINVL Pensija 1982-1988_20200605_ltINVL Pensija 1989-1995_20200605_ltINVL Pensija 1996-2002_20200605_lt

London, June 8, 2020CNH Industrial N.V. (NYSE: CNHI / MI: CNHI) today announced the following updates on the $250 million  investment, made through its IVECO commercial vehicle segment, in Nikola Corporation (NASDAQ: NKLA) as a consequence of the completion, on June 3, 2020, of the previously announced merger between VectoIQ Acquisition Corp., a publicly-traded special purpose acquisition company, and Nikola Corporation (the ‘Merger’).Under the terms and conditions of the Merger, the former shareholders of Nikola received 1.901 shares of VectoIQ for every one share held in Nikola and became shareholders of VectoIQ, which, in turn, changed its name to “Nikola Corporation”. Nikola Corporation shares began trading on Nasdaq under the new ticker symbol “NKLA” on June 4, 2020.As a result of the Merger, IVECO now holds 25,661,449 shares of...

US FDA Grants Mexiletine Orphan Drug DesignationZug, Switzerland, 8 June 2019: Lupin is pleased to announce that the US Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to mexiletine hydrochloride for the treatment of myotonic disorders.Myotonic disorders are a group of heterogeneous, inherited, neuromuscular disorders characterized by a shared symptom called myotonia. Myotonia is an inability to relax a contraction of skeletal muscle which originates from a voluntary muscular contraction such as shaking someone’s hand and blinking, or everyday activities such as walking across a street and climbing stairs. Mexiletine reduces myotonia symptoms, resulting in a significant improvement in patient quality-of-life and other functional outcomes1.The FDA grants ODD status to medicines intended for the treatment, diagnosis...

COPENHAGEN, Denmark, June 8, 2020 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today topline results from the the first-in-human trial of MVA-BN® WEV, a prophylactic vaccine candidate against three equine encephalitis viruses (western, eastern and Venezuelan), for which there are currently no preventative vaccines available.The Phase 1 trial, funded by the United States Department of Defense’s (DOD) Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense’s (JPEO-CBRND) Joint Project Manager for Chemical, Biological, Radiological, and Nuclear Medical (JPM CBRN Medical) was designed to evaluate the safety, tolerability and immunogenicity of MVA-BN WEV in 45 healthy adults in three treatment groups receiving different doses of the vaccine. All subjects were revaccinated after four weeks.Data...

KØBENHAVN, Danmark, 8. juni 2020 – Bavarian Nordic A/S (OMX: BAVA) offentliggjorde i dag toplinjeresultater fra det første forsøg i mennesker med den forebyggende vaccinekandidat MVA-BN® WEV mod tre typer af hesteencephalit virus (vestlig, østlig og venezuelansk), mod hvilke der ikke findes vacciner i dag.Fase 1-forsøget, der er finansieret af det amerikanske forsvar, United States Department of Defense’s (DOD) Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense’s (JPEO-CBRND) Joint Project Manager for Chemical, Biological, Radiological, and Nuclear Medical (JPM CBRN Medical), var udformet til at evaluere sikkerheden, tolerabiliteten og immunogeniciteten af MVA-BN WEV i 45 raske voksne i tre grupper, der blev vaccineret med forskellige doser af vaccinen. Forsøgspersonerne blev revaccineret efter...

Sanofi to present Phase 3 results of avalglucosidase alfa in patients with late-onset Pompe diseaseVirtual scientific session June 16, 2020, 8:00-9:00am ET/2:00-3:00pm CETAvalglucosidase alfa receives FDA Breakthrough Therapy designationPARIS – June 8, 2020 – Sanofi will host a virtual scientific session to present data from the Phase 3 COMET trial of investigational enzyme replacement therapy (ERT) avalglucosidase alfa in patients with late-onset Pompe disease (LOPD).  The session, open to healthcare professionals and members of the media, will include a data presentation by Jordi Diaz-Manera, M.D., Ph.D., Professor of Neuromuscular Disorders, Translational Medicine and Genetics at the John Walton Muscular Dystrophy Research Center, Newcastle University, UK, and Professor of Neuromuscular Diseases, Translational Medicine and Genetics...

Sanofi va présenter les résultats de phase III de l’avalglucosidase alpha chez des patients atteints de la forme tardive de la maladie de Pompe                                                                                                                                                           Session scientifique virtuelle le 16 juin 2020, 8 h 00 – 9 h 00 ET / 14 h 00 -15 h 00 CETL’avalglucosidase alpha reçoit la désignation de thérapie révolutionnaire par la FDAPARIS – Le 8 juin 2020 – Sanofi annonce la tenue d’une session scientifique virtuelle pour présenter les données de l’essai de phase III COMET consacré à l’avalglucosidase alpha, son enzymothérapie substitutive expérimentale pour le traitement de la forme tardive de la maladie de Pompe. Réservée aux professionnels de santé et à la presse médicale, cette session comprendra...

                                             Les Ulis, le 8 juin 2020LEXIBOOK : OBTENTION D’UN PRET GARANTI PAR L’ETAT DE 2.18 M€ AUPRES DE SES PARTENAIRES BANCAIRES.Afin de permettre au Groupe de traverser sereinement la crise du Covid-19 et d’assurer son développement en profitant de la reprise économique post-confinement, Lexibook a sollicité auprès de ses partenaires bancaires un Prêt garanti par l’Etat de 2.18 M€.L’ensemble des partenaires bancaires a validé la stratégie et le plan présentés par le Groupe. La BPI ayant également donné son agrément, ce Prêt Garanti par l’Etat (PGE) est en cours de mise en place. Il permettra ainsi d’aborder sereinement la saison 2020 et de sécuriser les approvisionnements de la saison de Noël. Celle-ci verra la sortie de plusieurs innovations que Lexibook présentera dans les prochaines semaines, et...

Pressemeddelelse                                                                                          8. juni 2020Scape Technologies sætter igen nye standarder for brugervenlig bin-picking med overlegen stabilitet.Scape Technologies har lanceret en ny simplificeret brugergrænseflade til SCAPE Bin-Picker systemerne. Markedets mest stabile og fleksible bin-picking system er blevet enkelt og let at anvende, uden at der er gået på kompromis med systemets overlegne pålidelighed.Scape Technologies har nu nået en af de væsentligste milepæle, der blev fastlagt i forbindelse med selskabets IPO: Markant optimering af SCAPE Bin-Picker systemets brugervenlighed, der vil minimere den tid og de ressourcer, som kunder og partnere skal bruge på at implementere systemet og omstille til nye emner. Den gennemgribende make-over af brugeroplevelsen er...

SIKA ACQUIRES MARKET LEADER IN ROOFING AND WATERPROOFING SYSTEMS IN EGYPTSika has acquired Modern Waterproofing Group, a leading manufacturer of roofing and waterproofing systems in Egypt. The acquisition supplements and rounds off the product portfolio of Sika Egypt and offers new opportunities for growth in the Egyptian construction market. The acquired business generates annual sales of CHF 26 million.Modern Waterproofing is based in Cairo with a production facility in Badr City which is a logistically ideal location close to Cairo and the New Administrative Capital. It manufactures solutions for the waterproofing and roofing markets, focusing on a comprehensive range of modified bitumen membranes. As complementary products, the company also offers liquid coatings and insulation boards. With its solid reputation as a high-quality company,...